Features | Partner Sites | Information | LinkXpress
Sign In
TERARECON, INC.
SCHILLER AG
AMPRONIX

Patient Portal Now Available As a Cloud Service

By Medimaging International staff writers
Posted on 03 Mar 2013
A new patient portal encourages patients to securely access, share, and manage their medical images and radiology reports with healthcare providers. It also positions US healthcare providers to meet stage 2 meaningful use (MU) requirements. The portal will be available as a cloud service in March 2013.

Implementing the portal as a Vue Cloud Service, developed by Carestream Health (Rochester, NY, USA), provides the flexibility of a monthly fee, and it can accommodate more users without additional network expansions. Carestream manages remote access, networking requirements and security procedures for users of its cloud services, while also addressing regulatory compliance and service uptime.

MyVue is also available as an on-site portal for users of Carestream’s Vue picture archiving and communication system (PACS) and Vue Archive, a vendor-neutral archiving solution that supports third-party PACS platforms.

The Ferrara Hospital (Ferrara, Italy) conducted an on-site trade trial of the MyVue patient portal as an on-site deployment. The hospital serves a population of more than 350,000 and conducts about 150,000 radiographic scans yearly. “MyVue is very attractive for patients because it enables them to have immediate access to their reports and images from their homes. More than 98% of our patients who participated in the trial were so enthusiastic about the product that they decided to continue using it,” said Giorgio Benea, the hospital’s director of diagnostic imaging. “In addition to providing a more efficient way to deliver imaging data to patients, our hospital gains a favorable reputation for deploying truly innovative technology.”

When patients arrived at admissions, they were offered the option to access imaging exam findings using the new patient portal. Patients that accepted received a password and links to access their own personal web page that contained their exams.

“MyVue helps empower patients to play a greater role in their medical care and gives healthcare providers an important tool in building patient satisfaction and loyalty,” said Cristine Kao, Carestream’s global marketing manager for Healthcare Information Solutions. “And since it’s so convenient for physicians to use, MyVue can help enhance referral volumes.”

Ferrara patients found the MyVue portal easy to use. “The MyVue portal requires no special knowledge of computers or applications, since each section has clear directions to guide users,” Dr. Benea said. By clicking on intuitive icons, patients can share an imaging exam with physicians and can also download the files via the web.

The MyVue portal e-mails a secure login to each patient, and medical images and reports can be accessed through the secure login from a variety of Web-browser enabled devices. No software downloads are required for patients or physicians. MyVue’s HTML5 viewer can be deployed on web-enabled devices such as the iPad and complements Vue Motion, Carestream’s vendor-independent image viewer for clinicians and referring physicians. Both MyVue and Vue Motion can help increase referring physicians’ approval and boosts the exchange of imaging exams.

Related Links:
Carestream Health


RADCAL
RTI ELECTRONICS AB
SuperSonic Imagine

Channels

MRI

view channel
Image: The quantitative character of the novel 3D technique on MR scans from a patient with primary liver cancer is demonstrated. Images A and B show the scan of the patient before being treated with chemoembolization. The new 3D technique helped quantify the volume and distribution of viable tumor tissue (shown in red and yellow colors). Images C and D demonstrate MR scans acquired after the treatment. The new 3D method helped the radiologists to quantify the vast central destruction of the tumor after the treatment (the dead tumor is represented by the blue color) (Photo courtesy of Johns Hopkins Medicine).

3D MRI Offers Improved Prediction of Survival After Chemotherapy for Liver Tumors

Researchers are using specialized three-dimensional (3D) magnetic resonance imaging (MRI) scanning technology to accurately measure living and dying liver tumor tissue in order to quickly show whether... Read more

Ultrasound

view channel
Image: Siemens Healthcare has launched the HELX Evolution, the newest iteration of its Acuson S range of ultrasound imaging systems (Photo courtesy of Siemens Healthcare).

Ultrasound Imaging System Enhancements Include High Definition Transducers, Sophisticated Elastography, and Tissue Strain Analysis

New features designed for a range of ultrasound systems include enhanced image quality with a large 21.5-inch liquid crystal diode (LCD) monitor, high definition (HD) transducers, optimized contrast agent... Read more

Nuclear medicine

view channel
Image: Sagittal section of brain PET image at four hours after 64CuCl2 injection with disulfiram or D-penicillamine in MD model mice (Photo courtesy of the RIKEN Center for Life Science Technologies).

PET Imaging Used to Assess Effectiveness of Menkes Disease Treatments

Japanese scientists are using positron emission tomography (PET) imaging to visualize the distribution of copper in the body using lab mice. Copper distribution is deregulated in a genetic disorder called... Read more

General/Advanced Imaging

view channel

Secondary Light Emission Generated by Plasmonic Nanostructures May Improve Medical Imaging Technology

New clues into light emission at different wavelengths generated by elements known plasmonic nanostructures may help to improve medical imaging technology. A plasmon is a quantum of plasma oscillation. The plasmon is a quasiparticle resulting from the quantization of plasma oscillations just as photons, and phonons are... Read more

Industry News

view channel

Collaboration Expands Capacity for Proton Therapy Clinical Research and Patient Treatments

Varian Medical Systems (Palo Alto, CA, USA) and the Paul Scherrer Institute (PSI; Villigen PSI, Switzerland) are extending an existing collaboration in the field of proton therapy to offer patients more accurate cancer treatments using intensity-modulated proton therapy (IMPT). Under the agreement, Varian will also... Read more
 
Copyright © 2000-2014 Globetech Media. All rights reserved.